New in Orphan Drugs

Download Press Release: Shire Acquires Premacure AB

24 May 2013 / By jolene / Drug Discovery, Drug Safety, Market Access, Orphan Drugs / 0 comments

Lexington, MA, US- March 12, 2013- Shire announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein [...]

 

More in Orphan Drugs

• 

  OrphanReach: Healthcare at Home and QED partner on orphan diseases

  23 May 2013 / By Freya Smale / Orphan Drugs / 0 comments

   
• 

  Guest blog: The importance of content marketing for orphan drugs

  21 May 2013 / By Caroline Hornby / Orphan Drugs / 0 comments

   
• 

  Guest blog: FindZebra – a rare disease search engine

  20 May 2013 / By Caroline Hornby / Orphan Drugs / 0 comments

   
• 

  Download Press Release: Shire Supports Rare Disease Day 2013

  17 May 2013 / By jolene / Orphan Drugs, Uncategorized / 0 comments

   
• 

  Orphan drug Kalydeco now available in Wales

  15 May 2013 / By Tim / Featured on app, Orphan Drugs / 0 comments

   
• 

  Vertex Kalydeco case: Identifying biomarkers to articulate the value of an orphan drug – Charles Johnson

  14 May 2013 / By Tim / Featured Videos, Featured on app, Orphan Drugs / 0 comments

   
• 

  The challenges and opportunities of first therapies in DMD – Claudia Hirawat

  14 May 2013 / By Tim / Featured Videos, Featured on app, Orphan Drugs / 0 comments

   
• 

  Guest blog: What do rare disease patients want from pharma?

  13 May 2013 / By Caroline Hornby / Orphan Drugs / 0 comments

   
• 

  Download Press Release: Shire Acquires Lotus Tissue Repair, Inc

  10 May 2013 / By jolene / Drug Discovery, Drug Safety, Orphan Drugs / 0 comments

   
• 

  Whitepapers: Challenges Faced in Rare Disease Product Development & The Role of a Patient Association

  8 May 2013 / By Matt Turner / Clinical Trials, Orphan Drugs, Partnering & Investment / 0 comments